FINWIRES · TerminalLIVE
FINWIRES

セクター最新情報:金曜日の取引開始前、消費関連株はまちまちの動き

-- 金曜日の取引開始前、消費関連株はまちまちの動きとなった。ステート・ストリート・コンシューマー・ステープルズ・セレクト・セクターSPDR ETF(XLP)は小幅安、ステート・ストリート・コンシューマー・ディスクレショナリー・セレクト・セクターSPDR ETF(XLY)は0.1%高となった。 ウォール・ストリート・ジャーナル紙は、関係者の話として、ブラウン・フォーマン(BF.A、BF.B)がフランスの酒類メーカー、ペルノ・リカールとの協議が続く中、サゼラックから買収の可能性について打診を受けたと報じた。ブラウン・フォーマンの株価は取引開始前に1%以上上昇した。 中国の人工知能(AI)開発企業である盛樹科技(ShengShu Technology)は、TALエデュケーション・グループ(TAL)、百度(BIDU)をはじめとする複数のベンチャーキャピタルが、同社のシリーズB資金調達ラウンドに参加したと発表した。TALエデュケーション・グループの株価は取引開始前に1%以上上昇した。 JD.com(JD)の株価は、同社が100億中国人民元(14億6000万ドル)相当の無担保社債の発行を完了したと発表したことを受け、0.7%上昇した。

Related Articles

Asia

Clinuvel Unlikely to Seek Scenesse's Vitiligo Approval Before Phase 3 Completion, Says Jefferies

Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.

$ASX:CUV
Asia

ASX Preview: Australian Shares Set to Open Flat on Stalled US-Iran Talks; Origin Energy Reports Lower March Quarter Production

Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.

$^AXJO$ASX:IPX$ASX:ORG
Asia

Cobre Appoints Chief Financial Officer

Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.

$ASX:CBE